Page last updated: 2024-10-22

albuterol and Mitochondrial Diseases

albuterol has been researched along with Mitochondrial Diseases in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schreuder, LT1
Nijhuis-van der Sanden, MW1
de Hair, A1
Peters, G1
Wortmann, S1
Bok, LA1
Morava, E1

Other Studies

1 other study available for albuterol and Mitochondrial Diseases

ArticleYear
Successful use of albuterol in a patient with central core disease and mitochondrial dysfunction.
    Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3

    Topics: Activities of Daily Living; Adrenergic beta-2 Receptor Agonists; Albuterol; Child; Combined Modality

2010